Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time‐series analysis

OBJECTIVES: Patients with rheumatoid arthritis (RA) experience adverse events because of the characteristics of the disease and the side effects of medications. We investigated the trends of adverse events and mortality associated with disease‐modifying antirheumatic drugs (DMARDs). METHODS: We used...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yao‐Fan, Liu, Jia‐Rou, Chang, Shu‐Hao, Kuo, Chang‐Fu, See, Lai‐Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208285/
https://www.ncbi.nlm.nih.gov/pubmed/35759234
http://dx.doi.org/10.1002/iid3.630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208285/
https://www.ncbi.nlm.nih.gov/pubmed/35759234
http://dx.doi.org/10.1002/iid3.630

Ejemplares similares